Mogadon (Nitrazepam)

Nitrazepam, the active ingredient in Mogadon, is a benzodiazepine presented as an oral tablet for oral administration. It is indicated for the short‑term treatment of insomnia and for the management of anxiety disorders in adult patients.

GNH USA supplies Mogadon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Mogadon is manufactured under EU GMP guidelines, ensuring consistency and purity across batches.

Nitrazepam, a benzodiazepine, acts on the central nervous system to produce anxiolytic and hypnotic effects.

Insomnia: facilitates sleep onset and maintenance in adults. Anxiety disorders: reduces excessive worry and tension. Pre‑operative anxiety: provides calming effect before surgical procedures.

Nitrazepam may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy during waking hours. - Dizziness: sensation of light‑headedness or unsteadiness. - Impaired coordination: reduced motor control and balance. - Memory impairment: difficulty recalling recent events.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially when combined with other depressants. - Dependence and withdrawal: risk of physical dependence with prolonged use and potential withdrawal seizures upon abrupt cessation. - Severe skin reactions: rare events such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing or dispensing Nitrazepam, several safety considerations are recommended.

Assess patient history: evaluate for depression, substance abuse, or respiratory disorders. Avoid abrupt discontinuation: taper the dose under medical supervision to prevent withdrawal. Use caution in elderly: increased sensitivity may raise fall risk and cognitive impairment. Avoid concomitant CNS depressants: limit combined use with alcohol, opioids, or other sedatives. Pregnancy and lactation: discuss potential risks with the prescriber before use. Store at ambient temperature: keep in the original container, protect from moisture and heat.

Nitrazepam can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - Other benzodiazepines: additive central nervous system depression. - Opioids: heightened risk of severe respiratory depression. - Alcohol: increased sedation and impairment of psychomotor function.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs): may augment sedative effects. - Antihistamines: can enhance drowsiness. - CYP3A4 inhibitors (e.g., ketoconazole): may raise nitrazepam plasma concentrations.